$665 Million is the total value of Foyston, Gordon, & Payne Inc's 71 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 8.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MDT | Sell | Medtronic PLC. | $34,609,000 | -7.2% | 467,061 | -2.4% | 5.20% | -5.5% |
CAG | Sell | Conagra Foods Inc. | $30,259,000 | -18.3% | 692,105 | -31.8% | 4.55% | -16.8% |
PNC | Sell | PNC Financial Services Group Inc. | $25,521,000 | -11.2% | 266,820 | -13.5% | 3.84% | -9.6% |
MET | Sell | Metlife Inc. | $23,479,000 | +6.0% | 419,342 | -4.3% | 3.53% | +8.0% |
WBA | Sell | Walgreens Boots Alliance Inc. | $22,510,000 | -6.0% | 266,581 | -5.8% | 3.38% | -4.3% |
BG | Sell | Bunge Ltd. | $18,737,000 | +1.2% | 213,403 | -5.1% | 2.82% | +3.0% |
APA | Sell | Apache Corp. | $18,277,000 | -7.1% | 317,145 | -2.8% | 2.75% | -5.5% |
PFE | Sell | Pfizer Inc. | $17,958,000 | -6.3% | 535,581 | -2.8% | 2.70% | -4.6% |
JCI | Sell | Johnson Controls Inc. | $17,232,000 | -4.5% | 347,914 | -2.7% | 2.59% | -2.7% |
JNJ | Sell | Johnson & Johnson | $17,183,000 | -4.7% | 176,310 | -1.7% | 2.58% | -3.0% |
STT | Sell | State Street Corp. | $16,178,000 | +2.7% | 210,110 | -1.9% | 2.43% | +4.6% |
FCX | Sell | Freeport-McMoRan Copper & Gold Inc. | $15,023,000 | -7.2% | 806,845 | -5.5% | 2.26% | -5.5% |
AVT | Sell | Avnet Inc. | $14,686,000 | -9.2% | 357,243 | -1.7% | 2.21% | -7.6% |
CHKP | Sell | Check Point Software Technologies Ltd. | $14,246,000 | -13.9% | 179,082 | -11.3% | 2.14% | -12.4% |
TDW | Sell | Tidewater Inc. | $12,785,000 | +11.8% | 562,452 | -5.9% | 1.92% | +13.9% |
RGA | Sell | Reinsurance Group of America | $11,839,000 | -2.2% | 124,797 | -3.9% | 1.78% | -0.4% |
SEM | Sell | Select Medical Holdings Corp. | $11,782,000 | -5.2% | 727,274 | -13.2% | 1.77% | -3.4% |
TUP | Sell | Tupperware Brands Corp. | $11,317,000 | -8.6% | 175,346 | -2.2% | 1.70% | -6.9% |
ANF | Sell | Abercombie & Fitch Co. Cl A | $8,854,000 | -5.1% | 411,611 | -2.8% | 1.33% | -3.3% |
HWC | Sell | Hancock Holding Co. | $8,695,000 | -14.1% | 272,487 | -19.7% | 1.31% | -12.6% |
KT | Sell | KT Corp. - ADR | $7,987,000 | -3.7% | 630,410 | -0.5% | 1.20% | -1.9% |
COP | Sell | ConocoPhillips | $7,984,000 | -4.4% | 130,019 | -3.1% | 1.20% | -2.7% |
MRK | Sell | Merck & Co. Inc. | $7,864,000 | -5.9% | 138,137 | -5.0% | 1.18% | -4.2% |
KN | Sell | Knowles Corp. | $6,774,000 | -15.9% | 374,230 | -10.4% | 1.02% | -14.3% |
DOX | Sell | Amdocs Ltd. | $6,080,000 | -18.3% | 111,376 | -18.6% | 0.91% | -16.8% |
CAH | Sell | Cardinal Health Inc. | $5,798,000 | -9.5% | 69,317 | -2.4% | 0.87% | -7.8% |
SNY | Sell | Sanofi - ADR | $5,477,000 | -1.9% | 110,575 | -2.1% | 0.82% | -0.1% |
DVN | Sell | Devon Energy Corp. | $4,702,000 | -5.8% | 79,041 | -4.5% | 0.71% | -4.1% |
F | Sell | Ford Motor Co. | $4,521,000 | -11.5% | 301,212 | -4.8% | 0.68% | -9.8% |
SMFG | Sell | Sumitomo MITSUI-SPONS ADR | $4,343,000 | +11.8% | 488,566 | -2.7% | 0.65% | +13.8% |
ORCL | Sell | Oracle Corp. | $4,285,000 | -8.5% | 106,339 | -2.1% | 0.64% | -6.9% |
SWK | Sell | Stanley Black & Decker Inc. | $4,245,000 | +5.8% | 40,338 | -4.2% | 0.64% | +7.6% |
MTB | Sell | M&T Bank Corp. | $3,932,000 | -6.2% | 31,477 | -4.7% | 0.59% | -4.5% |
ABBV | Sell | AbbVie Inc. | $820,000 | +14.4% | 12,200 | -0.3% | 0.12% | +16.0% |
TAP | Exit | Molson Coors Brewing Co. - B | $0 | – | -10,280 | -100.0% | -0.11% | – |
DBD | Exit | Diebold Inc. | $0 | – | -41,112 | -100.0% | -0.22% | – |
FNB | Exit | F.N.B. Corp. | $0 | – | -259,542 | -100.0% | -0.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp. | 42 | Q3 2023 | 10.2% |
Johnson & Johnson | 42 | Q3 2023 | 9.3% |
Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
Coca Cola Co. | 42 | Q3 2023 | 1.7% |
Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
AbbVie Inc. | 42 | Q3 2023 | 0.5% |
Abbott Laboratories | 42 | Q3 2023 | 0.4% |
Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
13F-HR | 2024-02-07 |
13F-HR | 2023-10-26 |
13F-HR | 2023-08-01 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-04 |
13F-HR | 2022-08-11 |
13F-HR | 2022-04-27 |
13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.